We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MR Elastography Visualizes Tumor Stiffness and Density

By MedImaging International staff writers
Posted on 26 Oct 2019
Print article
Image: A map of tumor elasticity showing the marked stiffness of a pancreatic tumor (Photo courtesy of Yann Jamin/ICR).
Image: A map of tumor elasticity showing the marked stiffness of a pancreatic tumor (Photo courtesy of Yann Jamin/ICR).
A new study suggests that magnetic resonance (MR) elastography can noninvasively and quantitatively map the viscoelastic properties of tumors in vivo.

Researchers at University College London (UCL, United Kingdom), The Royal Marsden NHS Foundation Trust (London, United Kingdom), and the Institute of Cancer Research (ICR; London, United Kingdom) conducted a study in mice that coupled MR elastography and computational histopathology to interrogate the contribution of collagen to tumor biomechanical phenotype in several different tumor types, including breast cancer, pancreatic cancer, medulloblastoma, glioblastoma, and neuroblastoma xenografts.

The results revealed positive correlations between collagen fraction and both elasticity and viscosity, but not with cellular or vascular density, and that treatment with collagenase significantly reduced elasticity and viscosity. Analysis of the extracted images of picrosirius red staining revealed negative correlations with elasticity and viscosity and positive correlations of texture with fractal dimension, suggesting that MR elastography could provide sensitive imaging biomarkers of tumor collagen deposition and its therapeutic modulation. The study was published on October 11, 2019, in Cancer Research.

“There’s a lot of research activity centered on finding new therapies designed to help anti-cancer drugs reach their target in breast and pancreatic cancers, which can be so stiff and dense that they are impenetrable,” said senior co-author Yann Jamin PhD, of ICR. “We are very excited to have found a rapid scan that can be incorporated into a current routine clinical MRI examination and can potentially monitor the effects of these new tumor-weakening therapies, and assist the development and delivery of medicines which could save or extend lives.”

MR elastography is a dynamic elasticity imaging technique that uses mechanical waves to quantitatively assess the shear modulus (stiffness) of tissues. It can be considered as an imaging-based equivalent of palpation, often used to diagnose and characterize diseases, as the mechanical properties of tissues are often dramatically affected by disease processes, such as cancer, inflammation, and fibrosis. Data about the stiffness of tissue is obtained by assessing the propagation of mechanical waves via upgraded MRI scanners.

Related Links:
University College London
The Royal Marsden NHS Foundation Trust
Institute of Cancer Research

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
P20 Elite
Ultrasound Doppler System
Doppler BT-200
New
Ultrasound System
Acclarix AX9

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.